1 Departments of Pediatrics and Medicine, University of Vermont College of Medicine, Burlington, Vermont, and Wyeth Laboratories, Inc., Marietta, Pennsylvania
Thirty-three children ranging in age from 5 to 9 years were immunized with varying doses of bivalent A2 (Hong Kong variant) B subunit influenza vaccine. The immunization was given intramuscularly. There were no local or systemic reactions. Thirty-one of 33 children (94%) demonstrated four-fold or greater rises in antibody titer to type A antigen. Twenty-one of 33 (64%) showed four-fold or greater rises to type B antigen. A booster four weeks after immunization produced no significant increase in antibody titer. The subunit influenza vaccine, which is antigenic and well tolerated in children, should be considered for use if routine immunization of children against influenza is deemed desirable.
Submitted on January 17, 1973
This article has been cited by other articles:
![]() |
A. Kempe, M. F. Daley, J. Barrow, N. Allred, N. Hester, B. L. Beaty, L. A. Crane, K. Pearson, and S. Berman Implementation of Universal Influenza Immunization Recommendations for Healthy Young Children: Results of a Randomized, Controlled Trial With Registry-Based Recall Pediatrics, January 1, 2005; 115(1): 146 - 154. [Abstract] [Full Text] [PDF] |
||||